Efficacy of a Breathwork Practice (SKY) on Well-Being of Individuals With Parkinson's Disease (iPD) and Care Partners
Part of paid clinical trials in Coral Springs, Florida.
- Sponsor
- Nova Southeastern University
- Study ID
- NCT06581523
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Accepted
Interventions
- SKY Breath and Meditation — BEHAVIORALSKY Breath and Meditation is a unique breath-based technique that uses cyclical, rhythmic patterns of breath to bring the mind and body effortlessly into meditation. It has been empirically validated and holds distinct advantages over other forms of meditation.
Study Details
The goal of this feasibility study and clinical trial is to learn if an evidenced-based breathwork and meditation intervention (SKY Breath) will improve the mental and physical well-being of individuals with Parkinson's Disease (iPD) in stages 1, 2, and 3, under the age of 75 and their care partners. The main questions it aims to answer are: * Objective 1: Can the SKY Breath practice be designed and implemented to specifically cater to the unique needs of individuals with Parkinson's Disease and their care partners. * Objective 2: Will the SKY Breath practice decrease stress levels (a contributor to increasing PD symptoms) for individuals with Parkinson\'s Disease (iPD) and their care partners as measured through self-reported surveys to improve overall well-being and quality of life. * Objective 3: Will the SKY Breath practice in part alleviate the emotional stress and physical burden experienced by care partners of PD patients, promoting their resilience and well-being. Participants will be asked to learn the SKY Breath and Meditation practice over the course of 4 days (2.25 hours each morning), practice SKY every day for 4 weeks and keep a log of time spent doing SKY. The participants will complete a series of surveys before learning the practice and then after at weeks 1, 4 and 8. The series of surveys will take about 20 minutes.
Key Dates
- Start date
- Oct 19, 2024
- Status verified
- Feb 2026
- Primary completion
- Apr 30, 2026
- Completion
- Apr 30, 2026
Study Design
- Enrollment
- 40 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Individual with Parkinson's DiseaseThe intervention is the Sudarshan Kriya Yoga or SKY Breath and Meditation Practice. This will be taught over a 10-12 hour period, 2.25 hours for 4 early mornings. The participants will practice 6 days a week (a 35-45 minute practice)for a total of 8 weeks.
- Experimental: Care Partner of Individual with Parkinson's DiseaseThe intervention is the Sudarshan Kriya Yoga or SKY Breath and Meditation Practice. This will be taught over a 10-12 hour period, 2.25 hours for 4 early mornings. The participants will practice 6 days a week (a 35-45 minute practice)for a total of 8 weeks.
Primary Outcome Measure
Stress management for Individuals with Parkinson's Disease [ Time Frame: Pre-intervention, and 2 weeks, 4 weeks, 8 weeks post intervention ]
Central Contacts
- Venetia Bennett, BS, MS, PhD954-263-6535
- Sharon C Siegel, DDS, MS, MBA410-935-8857
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Raw Kickboxing and Fitness | Coral Springs | Florida | 33071 | Mark Barker, BA 954-575-6000 Allie Barker 954-309-7814 |
| David Posnack Jewish Community Center | Davie | Florida | 33328 | |
| Nova Southeastern University | Fort Lauderdale | Florida | 33328 | Venetia Bennett, BA, MS, PhD (PRINCIPAL_INVESTIGATOR) Rania Massad, BA, DPT (SUB_INVESTIGATOR) Sharon C Siegel, DDS, MS, MBA (SUB_INVESTIGATOR) Ronnie Newman, BA,CA, EdM (SUB_INVESTIGATOR) |
Find similar trials in Coral Springs, FL
Related Studies
- Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS RegistryRecruiting · Boston Scientific Corporation · Aliso Viejo, California
- Parkinson's Foundation PD GENEration Genetic RegistryRecruiting · Parkinson's Foundation · Birmingham, Alabama
- A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's DiseasePHASE3 · Recruiting · Hoffmann-La Roche · Birmingham, Alabama
- A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's MedicationsRecruiting · Bayer · Phoenix, Arizona